Key diabetes drug study was flawed, review charges

by on 10/07/10 at 2:44 pm

The popular diabetes drug Avandia may be far more dangerous to patients than reported in a study touted by the drug’s manufacturer, according to a strongly worded report posted Friday by the Food and Drug Administration.

Read more.

Leave a Reply